iTeos Therapeutics (ITOS) Earnings Date, Estimates & Call Transcripts $7.77 +0.27 (+3.60%) Closing price 04:00 PM EasternExtended Trading$7.77 0.00 (0.00%) As of 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock iTeos Therapeutics Earnings Summary Upcoming Q2 Earnings DateMay. 9Before Market OpensEstimatedConsensus EPS (Apr. 28) -$0.94 Actual EPS (Apr. 28) -$0.80 Beat By $0.14 iTeos Therapeutics posted Q1 2025 earnings on April 28, 2025, reporting an EPS of -$0.80, which beat the consensus estimate of -$0.94 by $0.14. With a trailing EPS of -$3.31, iTeos Therapeutics' earnings are expected to decrease next year, from ($3.49) to ($4.24) per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)ITOS Upcoming EarningsiTeos Therapeutics' Q1 2025 earnings is scheduled for Friday, May 9, 2025Powered by Get iTeos Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on iTeos Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataITOS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ITOS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. iTeos Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.39-$0.68-$1.04Q2 20252-$1.17-$0.85-$1.01Q3 20252-$1.31-$0.82-$1.07Q4 20252-$1.46-$0.88-$1.17 FY 2025 8 -$5.33 -$3.23 -$4.28 Q1 20261-$0.98-$0.98-$0.98Q2 20261-$1.03-$1.03-$1.03Q3 20261-$1.08-$1.08-$1.08Q4 20261-$1.10-$1.10-$1.10 iTeos Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/9/2025(Estimated)--------4/28/2025Q1 2025-$0.94-$0.80+$0.14-$0.80$9.35M-3/5/2025Q4 2024-$1.14-$1.01+$0.13-$1.01--11/12/2024--$1.18-$1.05+$0.13-$1.05--8/8/2024--$1.04-$0.18+$0.86-$0.18$4.20M$35.00M5/10/2024Q1 2024-$1.02-$1.07 -$0.05-$1.07--3/6/2024Q4 2023-$1.03-$0.85+$0.18-$0.85$37.41M-11/7/2023Q3 2023-$1.20-$0.90+$0.30-$0.90--8/8/2023Q2 2023-$1.03-$0.96+$0.07-$0.96--5/10/2023Q1 2023-$0.99-$0.44+$0.55-$0.44$13.80M$12.60M iTeos Therapeutics Earnings - Frequently Asked Questions When is iTeos Therapeutics's earnings date? iTeos Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 9th, 2025 based off last year's report dates. Learn more on ITOS's earnings history. Did iTeos Therapeutics beat their earnings estimates last quarter? In the previous quarter, iTeos Therapeutics (NASDAQ:ITOS) reported ($0.80) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.94) by $0.14. Learn more on analysts' earnings estimate vs. ITOS's actual earnings. How much revenue does iTeos Therapeutics generate each year? iTeos Therapeutics (NASDAQ:ITOS) has a recorded annual revenue of $35 million. How much profit does iTeos Therapeutics generate each year? iTeos Therapeutics (NASDAQ:ITOS) has a recorded net income of -$112.64 million. ITOS has generated -$3.31 earnings per share over the last four quarters. What is iTeos Therapeutics's EPS forecast for next year? iTeos Therapeutics's earnings are expected to decrease from ($3.49) per share to ($4.24) per share in the next year. More Earnings Resources from MarketBeat Related Companies Wave Life Sciences Earnings X4 Pharmaceuticals Earnings Enliven Therapeutics Earnings Collegium Pharmaceutical Earnings Pharvaris Earnings Spyre Therapeutics Earnings Mineralys Therapeutics Earnings Intellia Therapeutics Earnings Nurix Therapeutics Earnings Gyre Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernMicrosoft Crushes Earnings, What’s Next for MSFT Stock?Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of EarningsAmazon's Earnings Will Make or Break the Stock's Comeback This page (NASDAQ:ITOS) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iTeos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iTeos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ITOS Stock Free ITOS Stock Alerts